CTRI/2015/10/006247进行中（未招募）4 期
A prospective, Post Marketing Surveillance study to study the safety and effectiveness of omalizumab in Indian patients with Chronic Spontaneous Urticaria refractory to standard of care
ovartis Healthcare Private Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. CSU patients prescribed with omalizumab as per approved package insert and who are not treated with omalizumab 6 months prior to entering the study.
- •2. Patients willing to participate in the study by providing written informed consent.
排除标准
- •1.Contraindication as per PI.
- •2.Patients simultaneously participating in other studies
- •Pregnant women should not be included except if, in the opinion of the investigator, the expected benefit outweighs the potential risk to the fetus.
研究者
相似试验
进行中（未招募）
1 期
Study To Evaluate The Safety And Efficacy Of Vfend® IV in Korean patientsEUCTR2017-000197-11-Outside-EU/EEAPfizer Inc.400
尚未招募
4 期
Post marketing surveillance study of Pitavastatin for evaluation of its safety and efficacy in patients with diabetes and high cholesterolCTRI/2013/05/003686Cadila Healthcare500
进行中（未招募）
不适用
reactogenicity and safety of Vaxem™HibMeningitis, epiglottitis, pneumonia, arthritis caused by Haemophilus influenzae type b.EUCTR2014-005203-24-Outside-EU/EEAovartis Vaccines and Diagnostics750
已完成
4 期
A study to assess the safety and tolerability of VELNEZ nasal pack after nasal surgeryCTRI/2018/04/013227Datt Mediproducts Pvt Ltd37
已完成
4 期
A study to assess the safety and tolerability of VELNEZ nasal pack after surgery of noseCTRI/2018/12/016535Datt Mediproducts Pvt Ltd40